Okudingeka Ukwazi Ngokuthatha I-Metformin Uma Unayo i-PCOS
Uma une-Polycystic Ovary Syndrome (i- PCOS ) futhi imisiwe i-metformin, kungenzeka ukuthi unemibuzo eminingi nokukhathazeka ngokuthatha le mithi. Abaningi besifazane abane-PCOS banamazinga aphezulu e-insulin abangela ukutholakala kwesisindo, izifiso, ngisho nama-dark patches esikhumbeni sakho. Ngokuhamba kwesikhathi, ukuvezwa kwamazinga aphezulu e-insulini kungenza ube ne- insulin ukumelana noma ube uhlobo lwesifo sikashukela .
I-Metformin isebenza ukunciphisa i-insulini yakho futhi unciphise ingozi yesifo sikashukela.
Lesi sihloko sizokukhombisa ukuthi yini okudingeka ukwazi ngokuthatha i-metformin uma une-PCOS.
I-Metformin isebenza kanjani?
I-Metformin ingenye yezidakamizwa ezindala kunazo zonke ezifundwayo e-United States. Amanye amagama we-metformin afaka i-Glucophage, i-Glucophage XR, i-glumetza, ne-fortamet. Nakuba kungabhalwa ukuthi kusetshenziswe kwabesifazane abane-PCOS, i-metformin ingenye yemithi ejwayelekile esetshenziswa ukuphatha lesi simo. I-Metformin iye yafundiswa emantombazaneni aseneminyaka engu-8 ubudala, abanye abacwaningi bayincoma ukuthi bavimbele ukuqala kwe-PCOS. I-Metformin isebenza njenge- insulin-sensitizer ukunciphisa ukukhiqizwa kwe-glucose. I-Metformin inciphisa i-blood glucose nezinga le-insulin ngezindlela ezintathu:
1. Iqeda ukukhiqizwa kwe-glucose yesibindi.
2. Ukwandisa ukuzwela kwesibindi sakho, imisipha, amafutha, namaseli kuya kwi-insulin umzimba wakho wenza.
3. Linciphisa ukumuncwa kwama- carbohydrates oyidlayo.
Isilinganiso esiphansi se-metformin kwabesifazane abane-PCOS singama-1,500 mg kuya ku- 2,000 mg nsuku zonke.
Izinzuzo zezeMpilo ze-Metformin
Ngaphandle kokunciphisa i-glucose yakho namazinga e-insulin, i-metformin inganikeza ezinye izinzuzo zezempilo kwabesifazane abane-PCOS. I-Metformin ingakwazi ukuthuthukisa i-ovulation nokulawula imijikelezo yokuya esikhathini.
Lokhu kusho ukuthi uma usebenza ngokocansi, kufanele usebenzise ukulawula ukubeletha ukuvimbela ukukhulelwa, ngisho noma ungakatholi isikhathi sakho njalo. I-Metformin ingathuthukisa ngisho ne-cholesterol nezimpawu ze-hirsutism ezinjenge-acne nokukhula kwezinwele ezidlulele. I-Metformin ingasisiza ngokulahlekelwa isisindo uma ihambisana nokudla okunempilo nokuzivocavoca kodwa akuyona isidakamizwa sokulahlekelwa isisindo. Ukuthatha i-metformin ngenkathi ukhulelwe kunganciphisa ingozi yesifo sikashukela sokugaya futhi kufanele kukhulunywe nodokotela wakho.
Kuthiwani Ngezimpembe Zemibala?
Ngokuvamile, iningi labantu lingakwazi ukubekezelela i-metformin kahle. Imiphumela emibi ejwayelekile lapho uqala ukuyithatha ihlobene ne-GI futhi ingafaka isicanucanu, igesi, ukubhuka, ukuhlukunyezwa kwesisu kanye nokuhuda. Abanye abantu bathola ukuthi i-prolonged release version ye-metformin ihle kakhulu ohlelweni lokugaya futhi ibekezelela kangcono.
I-Metformin kufanele ithathwe ngokudla ukunciphisa imiphumela emibi. Ukwandisa kancane umthamo we-metformin ngaphezu kwamasonto amaningana Kunconywa imiphumela emihle. Ukudla ukudla okunoshukela nokucutshungulwa kungadambisa imiphumela emibi ye-digestive ye-metformin futhi kufanele igwenywe. Ungase uthole usebenza nomuntu obhalisiwe wokudla okunomsoco ozinikele ngokukhethekile kwi-PCOS ewusizo ukwakha uhlelo lokudla olusebenza kangcono ngezidingo zakho eziyingqayizivele.
I-Metformin ingathinta ukumunwa kwe- vitamin B12 . Ukusetshenziswa kwesikhathi eside kanye nokulinganisa okuphezulu kwe-metformin kwandisa amathuba okuntula kwe-vitamin B12. Ukuntuleka kwe-vitamin B12 kungabangela ukushintsha kwemizwelo, ukulahlekelwa kwememori futhi kungabangela ukulimala okungapheli ebuchosheni nasesimweni sezinzwa. Kufanele wengeze ukudla kwakho nge-vitamin B12 futhi amazinga akho ahlolwe njalo ngonyaka. Amaphesenti athile kavithamini B12 kufanele abe> 450 pg / mL. Izinga eliphakeme le-serum homocysteine nama-urinary methylmalonic acid (i-MMA), izinga legolide ekuhloleni i-B12, likhombisa nokuntuleka kwe-B12.
I-Lactic acidosis ingumphumela ongavamile we-metformin.
Ukuphuza utshwala ngenkathi ku-metformin akukhuthazwa.
Ingabe Kukhona Izindlela Zokwemvelo Zokwemvelo?
Akukho okunye esikhundleni se-metformin kodwa kulabo bantu abangakwazi ukukubekezelela noma abafuni ukuthatha imithi enqunyiwe, kunezinye izindlela zokuthuthukisa ukuzwela kwe-insulin uma une-PCOS-ngaphandle kwemiphumela emibi. Okubaluleke kunazo zonke ukulandela ukudla okunempilo nokuhlanganyela emsebenzini ovamile. I-N-acetyl cysteine i-antioxidant eyaboniswa esilingo esisodwa esilawulwa ngokungahleliwe ukusebenza kanye ne-metformin yokunciphisa i-insulin ne-cholesterol kwabesifazane abane-PCOS. I-Myo-inositol itholakele ukubuyisela ukuvuthwa okubangelwa ukukhulelwa okungaphezulu kune-metformin. I-Myo-inositol nayo iboniswe ukuthuthukisa i-insulin nezinye izici ze-PCOS ze-metabolic.
> Imithombo:
> Bailey, C. no Turner, R. Metformin. N Engl J Med. 1996; 334: 574-579
> Ibáñez L1, uLópez-Bermejo A, Díaz M, Marcos MV, de Zegher F. Ukwelashwa KweMetformin Eyodwa (iminyaka eyi-8-12) emantombazaneni anengqamuzana yokuhamba phambili ukuze anciphise iHirsutism, i-Androgen Excess, ne-Oligomenorrhea e-Adolescence. J Clin Endocrinol Metab. 2011 Aug; 96 (8): E1262-7. doi: 10.1210 / jc.2011-0555.
> Zhuo Z, Wang A, Yu H. Imiphumela ye-Metformin Intervention Ngesikhathi sokukhulelwa ku-Gestational Diabetes Mellitus kwabesifazane abane-Polycystic Ovary Syndrome: Ukubuyekezwa Okuhlelekile kanye nokuhlaziywa kwe-Meta-Analysis. I-Diabetes Res. 2014; 2014: 381231.
> I-Oner G, i-Muderris II. Imitholampilo, i-Endocrine ne-Metabolic Effects ye-Metformin vs N-Acetyl-Cysteine kwabesifazane abane-Polycystic Ovary Syndrome. I-Eur J Obstet Gynecol I-Biol ephikisayo. 2011.
> I-Costantino D, i-Minozzi G, i-Minozzi E, i-Guaraldi C. I-Metabolic ne-Hormonal Imiphumela ye-Myo-Inositol ku-Women With Polycystic Ovary Syndrome: Isivivinyo Esisiphambene Nesibili. Ukubuyekeza kwe-Europ Med Pharmacol Sci. 2009; 13 (2): 105-110.
> Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Metabolic and Hormonal Effects of Myo-Inositol kwabesifazane abane-polycystic ovary syndrome Ukubuyekeza kwe-Europ Med Pharmacol Sci. 2011; 15 (4): 452-457.
> Le Donne M, Alibrandi A, Giarrusso R, Lo Monaco I, Muraca U. [Ukudla, Metformin kanye ne-Inositol ku-Overweight kanye nabesifazane abakhona abane-Polycystic Ovary Syndrome: Imiphumela yeComposition Composition]. Minerva Ginecologica. 2012; 64 (1): 23-29.
> Venturella R, Mocciaro R, De Trana E, D'Alessandro P, Morelli M, Zullo F. [Ukuhlolwa Kokuguqulwa Kwemitholampilo, I-Endocrinal kanye ne-Metabolical Profile of Patients With PCOS Syndrome Ephathwa Ngama-Myo-Inositol]. Minerva Ginecologica. 2012; 64 (3): 239-243.
> Genazzani AD, Prati A, Santagni S, et al. Ukuhlukahluka kwe-Insulin Ukuphendula ngokulawulwa kwe-Myo-Inositol ku-Obese Polycystic Ovary Syndrome Iziguli. I-Gynecol Endocrinol. 2012; 28 (12): 969-973.
> Gerli S, Papaleo E, Ferrari A, Di Renzo GC. I-Randomized, i-Blum Double Blind Placebo-Controlled Trial: Imiphumela ye-Myo-Inositol ku-Umsebenzi we-Ovarian nama-Metabolic Factors kwabesifazane abane-PCOS. I-Europ Rev Med Pharmacol Sci. 2007; 11 (5): 347-354.
> I-Raffone E, i-Rizzo P, i-Benedetto V. I-insulin i-Agent Sensitiser Agents eyedwa kanye ne-Co-Treatment ne-R-Fsh yokukhishwa kwe-Ovulation ku-Pcos Women. I-Gynecol Endocrinol. 2010; 26 (4): 275-280.
> Galazis N, Galazi M, Atiomo W. d-Chiro-Inositol kanye Nokubaluleka Kwalo ku-Polycystic Ovary Syndrome: Ukubuyekezwa Okuhlelekile. I-Gynecol Endocrinol. 2011; 27 (4): 256-62
> Papaleo, E., Unfer, V., iBaillargeon, JP, et al. (2007). I-Myo-Inositol ezigulini ezine-Polycystic Ovary Syndrome: Indlela Yokufunda Ye-Ovulation Induction. I-Endocrinology ye-Gynecological, 23 (12): 700-703.